Trial intelligence / Profile preview

Oral dyclonine mucilage versus tetracaine spray for awake endotracheal intubation

ChiCTR1900023151Phase 4Not yet recruiting

Sponsor
First Medical Center of Chinese PLA General Hospital
Start
Jan 2019
Modality
Small Molecules, Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
Countries
1
01

Overview

Phase 4, open-label trial of dyclonine and tetracaine in None (2 arms), sponsored by First Medical Center of Chinese PLA General Hospital. Primary endpoint: Mean arterial pressure. Planned start Jan 2019; status: not yet recruiting.

02

Drugs

dycloninetetracaine

Beyond the preview

Go deeper on ChiCTR1900023151.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on ChiCTR1900023151.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call